Healthcare M&A and Valuation
News and Insights

On September29, 2025, Ambac Financial Group, a specialty financial services company focused on insurance, reinsurance, and related risk-based products, announced its acquisition  of ArmadaCare, a provider of comprehensive home care and personal support services serving aging and medically complex populations. ArmadaCare’s offering includes non-medical personal care, companion support, and community-based assistance tailored to seniors and individuals with functional limitati

On September 26, 2025, dentalcorp Holdings Ltd. (TSX: DNTL), Canada’s largest dental service organization (DSO), entered into a definitive arrangement agreement to be acquired  by investment funds affiliated with private equity firm GTCR in an all‑cash take‑private transaction valued at approximately C$2.2 billion on an equity basis and C$3.3 billion on an enterprise value basis, or roughly $2.4 billion USD. The acquisition deepens GTCR’s presence in the dental services and m

On September 22, 2025, Premier, Inc. a Charlotte‑based, technology‑driven healthcare improvement company specializing in supply chain solutions, data analytics, consulting and collaborative services for hospitals, health systems and other providers, agreed to be acquired  by an affiliate of dedicated healthcare investment firm Patient Square Capital in a take‑private transaction valued at approximately $2.6 billion. Under the terms of the deal, Premier stockholders are receiv

On September 23, 2025, Privia Health Group, Inc. (Nasdaq: PRVA)  entered into a definitive agreement to acquire  the Accountable Care Organization (ACO) business of Evolent Health, Inc. (NYSE: EVH), operating under the Evolent Care Partners (ECP) brand. The transaction provides Privia with more than 120,000 attributed lives across the Medicare Shared Savings Program (MSSP) as well as various commercial and Medicare Advantage programs, expanding Privia’s total value‑based care

On September 16, 2025, Strata Critical Medical, Inc. (Nasdaq: SRTA)  announced the acquisition  of Keystone Perfusion Services LLC, a leading provider of organ recovery and normothermic regional perfusion (NRP) services, in a transaction valued at approximately $124 million in upfront consideration. The purchase price was paid roughly 88 % in cash and 12 % in Strata common stock, and Strata agreed to additional contingent earn‑outs of up to $23 million tied to future gross pr